Fig. 1.
Median survival times of advanced renal cell carcinoma patients according to treatment with IFN-α and percentage of CD8highCD57+ lymphocytes in CD8+ subset (in peripheral blood) [51]
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.